
News from CNIO
We’ve assigned a rating of Unknown factuality to CNIO. You can read more about how we’ve determined CNIO’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top CNIO News

France · FranceA decade after the first steps of virotherapy, the medical world goes further. Scientists have succeeded in transforming the herpes virus into a formidable weapon against cancer. A phase 1/2 clinical trial has just proved this: the RP1, a genetically modified herpes simplex virus, has succeeded in reducing advanced melanoma tumours, even deeply rooted in the body. A discovery that could well change the deal for thousands of patients.See the Story
A Modified Herpes Virus Attacks Skin Cancer: Hope in Sight?

Madrid, Spain · MadridCAR-T therapies are a type of personalized immunotherapy in which the patient’s defensive cells are modified in the laboratory to strengthen their ability to recognize and destroy tumor cells. Their use, increasingly frequent in adults, is still reduced in pediatrics. The European Society of Pediatric Oncology has already warned that the low incidence of childhood cancer “limits their commercial interest”, and has called for a regulatory environ…Read Article
Cnio Pediatric Cancer Unit Award
Cnio Celebrates the Solidarity of Its Friends, Key to Attracting Talent and Advancing Cancer Research
Air pollution may be raising risk of lung cancer in ‘never-smokers’: Study
65% Center coverage: 20 sources
Roger Castells-Graells Receives Hawk Biosystems Award From the Society of Biophysics of Spain
Mariano Barbacid, Added Value Award for Science and Research
CNIO Creates 'Protein Nanoparticles' to Accelerate the Development of Anticancer Drugs
A Machine Learning Approach to Identify Predictive Molecular Markers for Cisplatin Chemosensitivity Following Surgical Resection in Ovarian Cancer
Coverage: 2 sources